Progressive multifocal leukoencephalopathy as the first presentation of sarcoidosis

Maha Elbadri1, Gordon Plant2

  • 1Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square, London, UK mmelbadri@hotmail.com.

BMJ Case Reports
|August 28, 2020
PubMed

Insights

Diagnosing progressive multifocal leukoencephalopathy (PML) in neuroinflammatory patients is challenging. This case highlights PML co-occurring with sarcoidosis, impacting prognosis and treatment decisions.

Area of Science:

  • Neuroimmunology
  • Infectious Neurology
  • Oncology

Background:

  • Diagnosing progressive multifocal leukoencephalopathy (PML) in patients with pre-existing neuroinflammatory conditions presents significant clinical challenges.
  • Delayed or inaccurate diagnosis of PML can lead to disease progression and erroneous prognoses for both PML and the primary condition.

Observation:

  • An unusual case involved a patient experiencing rapid visual decline, elevated serum angiotensin-converting enzyme (ACE), and lymphadenopathy.
  • The patient presented with progressive subcortical lesions and cerebrospinal fluid (CSF) positive for John Cunningham virus (JCV).

Findings:

  • The findings support a coincidental diagnosis of PML in a patient with sarcoidosis.
  • The presence of John Cunningham virus (JCV) in CSF confirmed PML.
  • Sarcoidosis-associated PML demonstrated an aggressive clinical course, comparable to PML associated with hematological malignancies.

Implications:

  • Accurate diagnosis of PML is crucial for establishing a precise prognosis of the primary condition, such as sarcoidosis.
  • Early PML diagnosis enables timely discontinuation of potentially harmful immunomodulatory treatments.
  • This case underscores the importance of considering coincidental PML in neuroinflammatory diseases, especially when clinical presentation is atypical.